Safety and Efficacy of CLS-TA by Anatomic Location of Inflammation: Results from the Phase 3 PEACHTREE Clinical Trial

CONCLUSIONS: Irrespective of the uveitic anatomic subtype among patients treated for ME associated with NIU, a clinical benefit in participants treated with CLS-TA was demonstrated, with a comparable safety profile.PMID:38194432 | DOI:10.1080/09273948.2023.2262015

Source: Ocular Immunology and Inflammation - January 9, 2024 Category: Allergy & Immunology Authors: Milan Shah Thomas Albini Quan Nguyen Charles Wykoff Mark Barakat Rahul N Khurana Barry Kapik Thomas A Ciulla Source Type: research